Type: Observational

Status of the trial: Completed

Orphan Drug Recognition: No

Inclusion

• Opening Date: 2010-12-23
• Closing Date: 2017-10-12

Criteria

Inclusion: Diagnosis of pediatric glaucoma or elevated intraocular pressure, continuously treated with latanoprost for at least 1 month within the year prior to the baseline examination

Exclusion: Pregnant or nursing females at baseline, a history of allergy or hypersensitivity to any of the ingredients contained in latanoprost

More information